Efficacy of Garenoxacin in Treatment of Experimental Endocarditis Due to Staphylococcus aureus or Viridans Group Streptococci

The activity of garenoxacin was investigated in rats with experimental endocarditis due to staphylococci and viridans group streptococci (VGS). The staphylococci tested comprised one ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus (MSSA) isolate (isolate 1112), one ciprof...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Entenza, José M., Vouillamoz, Jacques, Glauser, Michel P., Moreillon, Philippe
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2004
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC310157/
https://ncbi.nlm.nih.gov/pubmed/14693523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.1.86-92.2004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires